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Supplemtary materials and methods 
Plasmid construction 
Oligonucleotides were purchased from GeneWorks (Adelaide, Australia). Sequences of 
all PCR-generated inserts used in plasmid construction were confirmed by nucleotide 
sequence determination, using vector primers PET3 (5’-CGACTCACTATAGGGAGACC-
ACAAC) and PET4 (5’-CCTTTCGGGCTTTGTTAGCAG), or other gene-specific primers. 
pSJ1392 (αL): Plasmid pKO1341 contains dnaE between the NdeI and EcoRI sites of 
pETMCSI (Neylon et al, 2000). It was used as template for primer overlap extension 
PCR amplification of an internal portion of the dnaE[A921L,M923L] gene using the 
overlapping mutant primers 181 (5’-GCACGCCGAACAGATCCAGCTGACCGATAGCT-
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TCC) and 182 (5’-GGAAGCTATCGGTCAGCTGGATCTGTTCGGCGTGC) and outside 
primers 180 (5’-CCGGAAGAGATGGCTAAGCAACG) and 183 (5’-CATGTCTTTCAGC-
CTTACGCCTCC). The PCR product was isolated after digestion with SexAI and StuI 
and inserted between the same sites in pKO1341, that had been produced in an E. coli 
dcm strain to yield pSJ1392. This plasmid directs production of the αL mutant protein, 
under control of the phage T7 φ10 promoter.  
pKO1423 (αV832G): The dnaE+ plasmid pND517 (Wijffels et al, 2004) was used as 
template for mutagenesis using 5’-phosphorylated PCR primers 1861 (5’-PO4-GACGAC- 
GGCGAAATCGGCTATGGTATTGGCGCG) and 1862 (5’-PO4-GTTGACGTGGAAATG-
GTAAAGACCGGAG) and the Phusion site-directed mutagenesis kit (New England 
BioLabs), to generate pKO1423. This IPTG-inducible tac promoter plasmid directs 
production of the αV832G protein. 
pKO1430 (αΔ7): Similar mutagenesis of dnaE+ plasmid pND517 using PCR primers 
1879 (5’-PO4-TAATACAGGAATACTATGAGTCTGAATTTCCTTGA) and 1880 (5’-PO4-
CTCCGAACCAATGAGGCCACGGAGATCGTTTAATAAAC) and the Phusion kit yielded 
pKO1430, containing a dnaE gene missing the last seven codons (encoding QVELEFD). 
This plasmid directs overproduction of the αΔ7 protein under the transcriptional control 
of the tac promoter. 
pKO1428 (εD12A): The dnaQ+ plasmid pSH1017 (Hamdan et al, 2002) was first used as 
template for site-directed mutagenesis (Phusion kit) to make a plasmid with an NdeI site 
containing the dnaQ start codon, using primers 1618 (5’-PO4-AGCACTGCAATTACAC-
GCCAGATCGTTCTC) and 1619 (5’-PO4-CATATGGGGAATTAACCTCCTTAGGATCC-
GATTAAAC). This plasmid was used as template to make a further plasmid containing 
the dnaQ[D12A] gene using the same technique and primers 1619 and 1625 (5’-PO4-A-
GCACTGCAATTACACGCCAGATCGTTCTCGCCACCGAAACCACCGG). This plasmid 
was then digested with NdeI and EcoRI and the resulting dnaQ[D12A] fragment inserted 
into pETMSCI between the same restriction sites to yield pKO1428. This plasmid directs 
production the εD12A protein under the transcriptional control of the phage T7 φ10 
promoter. 
pKO1429 (εD12A,E14A): Plasmid pKO1428 was used as template for mutagenesis with 
PCR primers 1874 (5’-PO4-ATCGTTCTCGCCACCGCAACCACCGGTATGAAC) and 
1875 (5’-PO4-CTGGCGTGTAATTGCAGTGCTCATATG) and the Phusion kit, to produce 
pKO1429. This plasmid directs production of εD12A,E14A. 
 3 
pSJ1445 (εQ): Plasmid pSH1017 (Hamdan et al, 2002) was used as template for primer 
overlap PCR amplification of the dnaQ[Q182A] gene using overlapping mutagenic 
primers 406 (5’-CGATGACCGGTGGTGCAACGTCGATGGC) and 407 (5’-GCCATCGA-
CGTTGCACCACCGGTCATCG) and outside vector primers PET3 and PET4. The PCR 
product was isolated from an agarose gel following digestion with BamHI and EcoRI and 
inserted between the same sites in pETMCSII (Neylon et al, 2001) to place the gene 
under transcriptional control of the phage T7 φ10 promoter in plasmid pSJ1445. 
pSJ1446 (εL): This plasmid, containing the dnaQ[T183L,M185L,A186P,F187L] gene was 
made similarly to pSJ1445, using overlapping primers 408 (5’-GGCGATGACCGGTGG-
TCAACTGTCGCTGCCGCTGGCGATGGAAGGAGAGACAC) and 409 (5’-GTGTCTCT-
CCTTCCATCGCCAGCGGCAGCGACAGTTGACCACCGGTCATCGCC); pSJ1446 
directs overproduction of the εL protein. 
pSJ1482 (ubq-εCTS): Plasmid pSH1017 (Hamdan et al, 2002) was used for PCR 
amplification of the 3’ portion of dnaQ using the forward primer 489 (5’-AAAACCGCGG-
TGGTCAAACGTCGATGGCTTTTG), designed to incorporate a SacII site at the codon 
for Gly180, and reverse primer PET4, preserving an EcoRI site just following the stop 
codon. The isolated PCR product was inserted in-frame between the SacII and EcoRI 
sites following the His6-ubq gene in pKL1426 (Yagi et al, 2010) to yield pSJ1482. This 
T7 promoter vector positions the gene for expression of εCTS (C-terminal segment of ε, 
residues 181–243) fused to the C-terminus of His6-tagged human ubiquitin. 
pCM1503 (His6-βwt): Plasmid pND262 (Oakley et al, 2003) was used as a template for 
PCR amplification of the dnaN gene using primers 414 (5´-A10CATATGAAATTTACCG-
TAGAACGTGAGCATTTATTAAAACCGC), designed to incorporate a NdeI site as part 
of the start codon, and 417 (5´-TTGAATTCTTACAGTCTCATTGGCATGACAACATAAG-
CC), designed to incorporate an EcoRI site just following the TAA stop codon. The PCR 
product was isolated following digestion with NdeI and EcoRI and agarose gel 
electrophoresis and inserted between the same restriction sites in pCL476 (Love et al, 
1996) to yield plasmid pCM1503. This plasmid directs production of His6-βwt, with 
transcription of dnaN under control of tandem heat-inducible phage λ pR and pL 
promoters. 
pCM1531 (His6-βC): Plasmid pCM1531, which directs expression of His6-tagged βC, a 
version of the β clamp missing the C-terminal 5 residues (MPMRL) was constructed 
similarly to pCM1503, using forward primer 562 (5´-T10CATATGAAATTTACCGTAGAA-
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CGTGAGC and reverse primer 563 (5´-TTTTGAATTCTTAGACAACATAAGCCGCGCT-
CTGG). 
Protein purification 
Buffers were: A, 50 mM Tris.HCl pH 7.6, 5 mM MgCl2, 2 mM dithiothreitol (DTT), 1 mM 
ATP, 20% (v/v) glycerol; B: 25 mM Tris.HCl pH 7.6, 5 mM DTT, 1 mM EDTA, 20% (v/v) 
glycerol; C: 50 mM Tris.HCl pH 7.6, 2 mM DTT, 0.5 mM EDTA, 10% (v/v) glycerol; D: 30 
mM Tris.HCl pH 7.6, 2 mM DTT, 1 mM EDTA; E: 50 mM Tris-HCl, pH 7.6, 2 mM DTT, 1 
mM EDTA; F: 50 mM Tris-HCl, pH 7.6, 5 mM DTT, 1 mM EDTA, 20% (v/v) glycerol; G, 
35 mM Tris-HCl, pH 7.6, 0.5 mM DTT, 500 mM NaCl, 15% (v/v) glycerol. All protein 
purification steps were carried out at 2–6˚C.  
Pol III HE subunits: Overexpression and purification of subunits and complexes that 
constitute DNA polymerase III HE were described as follows: α, δ and δ’ (Wijffels et al, 
2004); γ and χ (Ozawa et al, 2005); β2 (Oakley et al, 2003); τ, refolded ψ within the χψ 
complex, τγ2δδ’(±ψχ) and τ3δδ’(±ψχ) complexes (Tanner et al, 2008); θ (Hamdan et al, 
2002). The α variants αΔ7, αL and αV832G were produced according to methods used for 
purification of wild-type α, except that αL production was induced in E. coli BL21 
(λDE3)/pLysS grown at 30˚C with 1 mM IPTG over 3 h. 
The ε variants (εwt, εL, εQ, εD12A and εD12A,E14A) were overproduced in E. coli BL21(λDE3) 
/pLysS strains containing plasmids pSH1017 (Hamdan et al, 2002), pSJ1446, pSJ1445, 
pKO1428, or pKO1429, respectively. Strains were grown individually at room 
temperature in LB autoinduction medium (Studier, 2005) containing ampicillin and 
chloramphenicol for 36 h. Cells were lysed using a French press and the pellets 
containing insoluble proteins were washed and ε refolded by the methods of 
Scheuermann and Echols, 1984. Protein(s) were then dialysed in Buffer B and applied 
onto a 5 ml column of SuperQ-650M resin equilibrated with the same buffer. After the 
column had been washed with 15 ml of Buffer B, ε was eluted in a single peak at 70 mM 
NaCl in a linear gradient (60 ml) of 0–400 mM NaCl in Buffer B. 
The ubq-εCTS fusion protein (Figure S1) was overproduced at 37˚C in strain BL21 
(λDE3)/pLysS/pSJ1482 in LB medium containing ampicillin and chloramphenicol by 
addition of IPTG. Lysis, pellet washing and refolding steps were done as for ε, except 
that washing steps at 1 M NaCl were omitted. The protein was then purified on a 1 ml 
HisTrap column (GE Healthcare) according to standard procedure for purification of 
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His6-tagged proteins (Figure S1B).  
Pol III core subassemblies: Pol III αεθ, αεLθ, αεQθ, αΔ7εθ and αLεθ cores were 
reconstituted from purified α, ε and θ proteins as described (Tanner et al, 2008). 
Protein(s) and complexes were dialysed in Buffer C+70 mM NaCl and applied onto a 5 
ml column of SuperQ-650M resin equilibrated with the same buffer. After the column 
had been washed with 20 ml of Buffer C+70 mM NaCl to remove excess of ε, θ, and εθ, 
pure core was eluted in a single peak at 150 mM NaCl in a linear gradient (20 ml) of 70–
1600 mM NaCl in Buffer C.  
The γ complex: The alternative clamp loader γ3δδ’ (non-proficient in assembling DNA Pol 
III HE) was made by mixing γ with equimolar excess of δ and δ’, thereby ensuring 
excess δ remained in complex with δ’ (δδ’ complex) to prevent precipitation due to the 
insolubility of δ. The mixture was dialysed in Buffer D+50 mM NaCl and applied onto a 5 
ml column of Q-Sepharose resin (GE Healthcare) equilibrated with the same buffer. 
After the column had been washed with 10 ml of Buffer D+50 mM NaCl, pure γ3δδ’ 
complex was eluted in a single peak at 270 mM NaCl in a linear gradient (190 ml) of 50–
450 mM NaCl in Buffer D. The peak was resolved from that containing excess δδ’ 
complex that eluted at 170 mM NaCl. 
Sliding clamps: (His6-βwt)2 was purified according to procedure for purification of β2 
(Oakley et al, 2003) except that one of the chromatographic steps using a DEAE-
Fractogel column was substituted by purification on a 1 ml HisTrap column. In contrast 
to its wild-type counterpart, overproduced (His6-βC)2 was insoluble. Following lysis in 
Buffer E, the insoluble pellet was washed twice in Buffer E+1 M NaCl and then twice in 
Buffer E (without NaCl). The pellet was then resuspended in Buffer F until 
homogeneous. Proteins were unfolded in denaturing Buffer F+3.5 M guanidine.HCl 
(Gu.HCl) and after addition of protease inhibitor cocktail C (Roche) according to the 
manufacturer’s prescription, made up to the composition of Buffer F+500 mM NaCl+1 M 
GuHCl and refolded by dialysis against two changes of Buffer F+500 mM NaCl. After 
centrifugation (35000 × g, 40 min), the supernatant containing refolded (His6-βC)2 was 
dialysed against two changes of Buffer G+35 mM imidazole and again clarified by 
centrifugation (35000 × g, 40 min). The supernatant was applied to a 1 ml HisTrap 
column that had been equilibrated in the same buffer. After the column had been 
washed with 15 ml of Buffer G, (His6-βC)2 was eluted at 170 mM imidazole in a linear 
gradient (10 ml) of 35–500 mM imidazole in Buffer G. The monomeric molecular mass of 
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the His6-βC measured by nanoESI-MS after dialysis into 0.1% (v/v) formic acid was 
40911 Da, corresponding well with the calculated mass of 40911.7 Da. 
To minimize undesired subunit exchange when preparing the His6-βwt/βwt and His6-βC/βwt 
heterodimers, all purification and dialysis steps (subsequent to the initial exchange) 
were carried out at 4˚C and as rapidly as possible. Samples of each purified mixed 
dimer were dialysed into 200 mM ammonium acetate, pH 7.2, and analysed by 
nanoESI-MS (Figure S2). 
The His6-βwt/βwt heterodimer was prepared by mixing an 8-fold molar excess of (βwt)2 
with (His6-βwt)2, and the mixture was dialysed against 3 changes of 2 l of Buffer SE1 (30 
mM Tris-HCl, pH 7.6, 1 mM dithiothreitol, 1 M NaCl, 10 mM MgCl2) containing 10% (v/v) 
glycerol for 12 h at 4˚C to allow subunit exchange, before being dialysed against 3 
changes of 2 l of isolation buffer  (30 mM Tris-HCl, pH 7.6, 30 mM NaCl, 0.5 mM 
dithiothreitol, 10% v/v glycerol, 30 mM imidazole) for a further 12 h. The sample was 
loaded onto a 1 ml Ni2+-charged HisTrap column (GE Healthcare) that had been 
equilibrated in the same buffer, then washed with 10 ml of the same buffer before being 
eluted with a linear gradient (10 ml) of 30–500 mM imidazole in isolation buffer. 
Fractions containing His6-βwt/βwt, which eluted at about 110 mM  imidazole, were 
immediately pooled and dialysed into 30 mM Tris-HCl, pH 7.6, 30 mM NaCl, 1 mM 
EDTA, 1 mM dithiothreitol, 30% (v/v) glycerol, giving a final yield of ~1 mg of His6-βwt/βwt 
in a total volume of 0.9 ml (13.4 µM). Aliquots were stored frozen at –80˚C until 
immediately before use.  
To prepare the His6-βC/βwt hemi-mutant heterodimer, a15-fold molar excess of (βwt)2 was 
added to (His6-βC)2, and the mixture was dialysed against 3 changes of 2 l of Buffer SE1 
for a total of 12 h at 4˚C, before being dialysed for a further 12 h against 3 changes of 2 l 
of isolation buffer (as above but containing 40 mM imidazole). The sample was loaded 
onto and eluted from a 1 ml Ni2+-charged HisTrap column as described above for the 
His6-βwt/βwt dimer. Fractions containing the His6-βC/βwt hemi-mutant, which eluted at 
~100 mM imidazole, were immediately pooled and dialysed into 30 mM Tris-HCl, pH 7.6, 
50 mM NaCl, 1 mM EDTA, 1 mM DTT, 30% (v/v) glycerol, yielding ~0.57 mg of His6-
βC/βwt in a volume of 3 ml (~2.3 µM). Aliquots were frozen in liquid nitrogen and stored at 
–80˚C until use.  
DnaBC complex: The DnaB helicase and DnaC helicase loader were as described in 
San Martin et al (1995). The DnaBC complex was made by mixing DnaB (11 mg) with 
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excess DnaC (10 mg) in 38 ml of Buffer A+100 mM NaCl+1 mM ATP and applied to a 5 
ml column of SuperQ-650M resin (Toyopearl) equilibrated in the same buffer. After the 
column had been washed with 20 ml of Buffer A+100 mM NaCl to remove excess DnaC, 
DnaBC was eluted in a single peak in a linear gradient (60 ml) of 100–800 mM NaCl in 
Buffer A.  
PriA, PriB and DnaT were prepared from overproducing strains by methods similar to 
those described by Marians (1995). 
DNA replication assays 
Preparation of 5’-flap-primed ssM13 DNA template: Wild-type phage M13 was purified 
from infected culture supernatants by PEG precipitation and banding (twice) in CsCl 
gradients. Phage were lysed, phenol extracted, and the ssDNA precipitated with 
ethanol, resuspended in and dialysed extensively against 10 mM Tris.HCl pH 8.0, 1 mM 
EDTA (TE buffer) and stored frozen at –80˚C. Oligonucleotide primer 48 has the 
sequence 5’-T36TATGTACCCCGGTTGATAATCAGAAAAGCCCCA-3’, consisting of a 
33-mer complementary to wild-type M13 DNA preceded at the 5’ end by a non-
complementary (dT)36 flap. M13 ssDNA (35 nM, as circles) was mixed with 1 µM of 
primer 48 in 30 mM Tris.HCl pH 7.6, 15 mM MgCl2, 130 mM NaCl and 0.1 mM EDTA. 
The mixture was treated at 55˚C for 10 min and then cooled slowly to room temperature 
over a period of 8 h. 
Preparation of TFII DNA template: The 5’-flap-primed ssM13 DNA template was pre-
filled in the standard SD reaction (see below; total volume 420 µl) but containing 14 nM 
DNA template and in the absence of SSB to prevent the Pol III SD reaction for 20 min. 
Products were separated on a 0.7% agarose gel in 2xTBE (180 mM Tris-borate, 4 mM 
EDTA) running buffer containing 1 µg/ml EtBr. Gel bands containing TFII were excised 
and the DNA isolated by electroelution into a dialysis sac (Sambrook and Russell, 
2001), extensively dialysed in TE buffer, concentrated to 1 ml using an Amicon Ultra-15 
centrifugal filter device and then to 120 µl using a QIAEX II Agarose Gel Extraction kit 
(Qiagen GmbH, Hilden, Germany). The final concentration in TE buffer was 35 nM TFII 
DNA. 
Coupled Pol III primer extension-strand displacement (SD) rolling circle assay: The 
standard SD replication reaction contained: 2.5 nM 5’-flap-primed M13 ssDNA template, 
1 mM ATP, 0.5 mM of each dNTP, 30 nM τ3δδ’ψχ clamp loader, 90 nM αεθ core, 200 
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nM β2 clamp and 750 nM SSB in buffer comprised of 25 mM Tris.HCl pH 7.6, 10 mM 
MgCl2, 10 mM DTT and 130 mM NaCl, in a final volume of 13 µL. When pre-assembled 
αεQθ or αεLθ cores or His6-βwt/βwt, His6-βC/βwt or (His6-βC)2 clamps were used, their 
concentrations were the same as of appropriate counterparts in the standard reaction. 
Assays containing various core sub-complexes assembled in situ contained 100 nM α or 
αV832G + 350 nM ε, εD12A, εD12A,E14A or ubq-εCTS ± 1 µM θ. To confirm the indispensability 
of the ψχ complex in SD synthesis, the standard assay contained 30 nM τ3δδ’ or τ3δδ’ψχ 
clamp loader complex, the latter assembled in situ with 30 nM τ3δδ’ and 110 nM ψχ. 
Likewise, the requirement for multiple τ subunits in Pol III SD synthesis was interrogated 
in standard reactions that had the τ3δδ’ψχ clamp loader substituted by one containing 50 
nM τγ2δδ’ψχ (one τ subunit) or with clamp loader assembled in situ from 50 nM γ3δδ’ and 
110 nM ψχ (no τ subunit). The requirement of the χ-SSB interaction for SD was 
assessed in the standard assay containing 750 nM SSBΔ8 (Mason et al, 2013) in place 
of SSB. 
Pol III strand displacement (SD) rolling circle assay: This was carried out in the standard 
reaction conditions except that the isolated TFII DNA template was used instead of the 
5’-flap-primed ssM13 DNA template. 
Assays of primer extension, under “difficult conditions”: Assays generally contained 2.5 
nM 5’-flap-primed ssM13 DNA template, 1 mM ATP, 0.5 mM of each dNTP, 10 mM DTT, 
40 nM γ3δδ’ clamp loader, 150 nM αεθ core and 200 nM β2 in 25 mM Tris.HCl pH 7.6, 10 
mM MgCl2 and 130 mM NaCl in final volume of 13 µl. Particular reactions contained wild 
type core substituted by α, or isolated αεLθ, αεQθ, αΔ7εθ or αLεθ complexes, each at 150 
nM. 
Replication components (except DNA) were mixed and treated for 5 min at room 
temperature to allow proteins to interact, cooled in ice and DNA added. The reactions 
were initiated by quick transfer to a 30˚C water bath, and quenched at indicated times by 
addition to 11 µl of 200 mM EDTA pH 8.0, 0.08% (w/v) bromophenol blue, 0.08% (w/v) 
xylene cyanol, 10% (v/v) glycerol, 2% (w/v) SDS. Reaction mixtures were treated for 2 
min at 42˚C, loaded onto a 0.8% agarose gel in 2×TBE buffer and electrophoresis 
carried out at 45 V for 180 min. Each gel was stained in 200 ml of SYBR® gold nucleic 
acid stain (Tuma et al, 1999) at the concentration suggested by the supplier (Invitrogen, 
Carlsbad, CA). DNA bands were visualized under 302-nm UV light using a Gel DocTM 
XR+ system (Bio-Rad, Hercules, CA). A corresponding DNA template sample was 
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loaded in one lane of each gel as a reference, as well as a sample of GeneRuler™ 1 kb 
Plus DNA Ladder (Thermo Fisher Scientific). 
Single molecule leading strand replication assays 
Continuous flow leading strand single molecule DNA replication assays were carried out 
essentially as described previously (Tanner et al, 2008; Tanner and van Oijen, 2009), 
with a few modifications concerning general and specific protein content and 
experimental conditions as described below. We also replaced the 24-mer primer on the 
leading strand at the fork with a 30-mer. Replication proteins were introduced in SM 
replication buffer [50 mM HEPES.KOH pH 7.9, 80 mM KCl, 12 mM Mg(acetate)2, 2 mM 
MgCl2, 5 mM DTT, 0.1 mg/ml bovine serum albumin, 1 mM ATP, and 195 µM of each 
dNTP and were present continuously in the flow calibrated to give a force of ~3 pN 
during the course of experiments at the following concentrations: 60 nM core 
polymerase (α or isolated αεθ, αεLθ or αεQθ), 30 nM τ3δδ’χψ clamp loader, 30 nM β2 
clamp, 30 nM isolated DnaB6(DnaC)6 helicase/loader complex, and the fork restart 
proteins PriA at 20 nM, PriB at 40 nM and DnaT at 480 nM. Experiments were done at 
32–34˚C. Data were acquired and treated as before except that pauses were selected 
as a minimum of six data points (images taken at 2 Hz) with amplitude fluctuations less 
than three times the standard deviations of the noise.  
Analysis of β2–ε  and α–ubq-εCTS interactions by gel filtration chromatography 
Analytical gel filtration was carried out at 4˚C using an Äkta FPLC system (GE 
Healthcare). Buffers were: GF1, 50 mM Tris.HCl pH 7.6, 150 mM NaCl, 2 mM DTT, 0.5 
mM EDTA and 20% glycerol; GF2, 30 mM Tris.HCl pH 7.6, 150 mM NaCl, 2 mM DTT, 
0.5 mM EDTA and 10% glycerol. 
Analysis of β2–ε interactions (Figure S3B) was carried out using mixtures of 17 µM β2 
and 57 µM ε, εQ or εL in 300 µl of Buffer GF1, treated overnight at 4˚C prior to loading 
onto and elution at 0.3 ml/min from a column (1 × 40 cm) of Sephacryl S-200 HR resin 
(GE Healthcare) equilibrated in Buffer GF1. Fractions of 500 µL were collected, and 
proteins in a portion (120 µl) of each were precipitated with ice cold acetone (700 µl). 
After 15 min on ice, protein pellets were collected by centrifugation (30000 × g; 60 min), 
dried for 10 min in air, dissolved in 25 µl of loading buffer and separated in 4–12% 
gradient SDS-PAGE gels (Invitrogen). Gels were stained with Coomassie blue. 
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Analysis of the interaction between α and ubq-εCTS (Figure S1C) was carried out 
similarly using a mixture of 7 µM α and 16 µM ubq-εCTS in 300 µl of Buffer GF2. Protein 
complexes were resolved on a column (1 × 40 cm) of Sephacryl S-100 resin (GE 
Healthcare), and analysed similarly, except that all of the collected fractions (500 µl) 
were treated with acetone in preparation for analysis by SDS-PAGE.  
Analysis of εpep–β2 interactions by multiplex SPR technology 
A 6 x 6 multiplex ProteOn XPR-36 Protein Interaction Array System was used for 
binding studies, carried out at 20˚C using the ProteOn™ NLC sensor chip with a 
NeutrAvidin-coated surface for immobilization of biotinylated ligands. The N-terminally 
biotinylated ε peptide ligands had sequences as follows: εLpep, bio-linker-GGQLSLPLAV 
(98% purity), εWTpep, bio-linker-GGQTSMAFAV (86%), and εQpep, bio-linker-
GGATSMAFAV (81%). Peptides were designed to incorporate the amino acid 
sequences (residues 182–187 in ε) proposed to interact with β2 in the middle of the 
decapeptide sequences. The two glycines at the N-terminus and the penultimate alanine 
are native to ε while the native methionine was substituted by valine at the C-terminus to 
improve peptide solubility as suggested by the supplier (Mimotopes Pty Ltd). An ε-
aminohexanoic acid linker was incorporated to distance protein-interacting residues from 
the surface of the sensor chip, onto which the peptide is immobilized. Peptides were 
dissolved to 1 mM in 100 mM Tris.HCl pH 7.6, 25% (v/v) acetonitrile. Purity of the 
peptides does not influence binding studies since only the authentic products contain 
biotin.  
All 36 interaction spots of the sensor chip were activated with three sequential injections 
of 1 M NaCl, 50 mM NaOH across six vertical (ligand) flow paths (40 s each at a flow 
rate of 40 µl/min) and six horizontal (analyte) flow paths (40 s each at 100 µl/min). The 
surface was further stabilized by two injections of 1 M MgCl2 in each direction, and with 
the same contact times and flow rates. Solutions of 100 nM εLpep, εWTpep and εQpep in 
SPR buffer [50 mM Tris.HCl pH 7.6, 50 mM NaCl, 0.5 mM tris(carboxyethyl)phosphine, 
0.2 mM EDTA, 0.005% surfactant P20 (GE Healthcare)] were injected for 33 s at a flow 
rate of 50 µl/min to immobilize each peptide onto a discrete ligand channel, to obtain 
responses of ~50, 70 and 60 RU, respectively, across 6 interaction spots. The chip was 
then rotated 90˚ and binding studies carried out by sequential injection of three different 
serially-diluted concentration series of β2 in SPR buffer (a, 0–0.098; b, 0–3.12; and c, 0–
100 µM), in the analyte direction at 100 µl/min for 60 s followed by dissociation in SPR 
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buffer over 300 s. Based on similar responses upon sequential injections of β2 at the 
same concentration over the immobilized β-binding peptide, as well as efficient and 
complete dissociation of the analyte, we confirmed the previous observation (Wijffels et 
al., 2004) that regeneration steps in this assay are unnecessary. The final sensorgrams 
were generated by double (two dimensional) reference subtraction (subtraction of the 
responses from corresponding interaction spots of a non-modified ligand flow path in 
one dimension and with [β2] = 0 in the second. Concentration series a and b were used 
for determination of KD(εLpep–β2) while the series c was used to determine KD(εWTpep–β2) 
and KD(εQpep–β2). 
Considering that fast on/fast off kinetics were observed, equilibrium responses (R) at 
various concentrations of β2 were used to fit binding isotherms to obtain KD and Rmax 
(response at saturation of ligand binding sites), using KaleidaGraph (Synergy software); 
for 1:1 binding, R/Rmax = [β2] / (KD + [β2]) [eq. 1]. Due to low responses (extremely weak 
binding) in the case of the εQpep–β2 interaction, the Rmax value was estimated based on 
values for the other two interactions and relative ratios of immobilized peptides, and the 
measured R with β2 at 50 µM was used in eq. 1 to estimate KD(εQpep–β2). 
Assessment of ε–β2 interactions by ESI-MS 
Protein samples for nanoESI-MS studies were prepared by dialysis against 5 changes of 
ammonium acetate (140–500 mM, as specified), pH 7.6, containing 1 mM β-
mercaptoethanol for a minimum 4 h per buffer change. Mass spectra for study of 
interactions of ε variants or purified αεθ containing ε variants with β2 (at indicated 
concentrations) were acquired in positive ion mode using nanoelectrospray ionization 
(nanoESI) on a Waters (Wythenshawe, UK) extended mass range Q-ToF Ultima™ 
mass spectrometer fitted with a Z-spray ESI source. Mass spectra were obtained using 
the following parameters: capillary voltage 1.5 kV, cone voltage 120 V, RF lens 1200 V, 
transport and aperture 5 V and collision energy 2 V. The pressure in the ion optics 
region was set to 0.1 mbar. Likewise, mass spectra showing interactions between β2 and 
in-situ assembled αεθ, including α and ε variants (at indicated concentrations) were 
acquired in positive ion mode using nanoESI on a Waters Synapt™ HDMS mass 
spectrometer fitted with a Z-spray ESI source. Parameters were: capillary voltage 1.5 
kV, cone voltage 150 V, extraction cone voltage 6 V, trap collision energy 10 V and 
transfer collision energy 6 V. The backing pressure was set to 6.5 mbar. Both 
instruments were calibrated using 10 mg/ml cesium iodide in 70% isopropanol/water. In 
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each study, 100–150 acquisitions were combined and the resulting spectrum was 
baseline subtracted and smoothed using the Savitzky-Golay algorithm. Spectra were 
acquired over a m/z range of 500–15000 and analyzed using MassLynx™ software. For 
illustrative purposes, only the relevant m/z range of each spectrum has been presented 
in the Figures.  
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Figure S1  Ubq-εCTS, an ε derivative that lacks the complete exonuclease domain, forms a stable 
complex with α. (A) Two-domain organization of ubq-εCTS. The flexible εCTS (residue numbering 
based on the E. coli ε sequence and shown in single letter code) was fused to human ubiquitin 
(79 residues) via the common Gly–Gly residue pair at the C-terminus of both ubiquitin and the N-
terminal exonuclease domain of ε. Arrows in εCTS indicate sites of proteolytic cleavage identified 
in Figure S1B. (B) Sites of cleavage by unidentified E. coli protease(s) in ubq-εCTS. SDS-PAGE 
analysis of successive fractions collected during elution of His6-ubq-εCTS from a Ni-NTA column. 
ESI-MS in 0.1% (v/v) formic acid was used to identify full-length His6-ubq-εCTS and N-terminal 
proteolytic fragments, where cleavage occurs at the C-terminal side of the indicated residues. 
(C) Full-length His6-ubq-εCTS forms a stable complex with α, isolable by gel filtration. Lower 
panel: The complex formed by mixing α (7 µM) and His6-ubq-εCTS (16 µM) was resolved from 
excess His6-ubq-εCTS and its proteolysis products using a column (1 x 40 cm) of Sephacryl S-100 
HR. Upper panel: For comparison, the same quantity of His6-ubq-εCTS was chromatographed on 
the same column. Samples from corresponding peak fractions were analysed on a 4–12% SDS-





Figure S2  Isolation of mixed β-dimers with both, one or no protein binding sites occluded. (A) 
Optimization of conditions for isolation of β2 heterodimers; high salt concentration promotes 
subunit exchange while low salt conditions stabilize the dimer. Equimolar mixtures (2 or 3 µM 
each) of (βwt)2 and (His6-βwt)2 in 30 mM Tris-HCl, pH 7.6, 1 mM dithiothreitol, containing either 10 
mM MgCl2 and 1 M NaCl (left panel) or 50 mM NaCl and 10% glycerol (right panel) were placed 
at 4˚C for 12 h, then dialysed against 200 mM ammonium acetate, pH 7.4 before analysis by 
positive ion nanoESI-MS. Assuming that (βwt)2, (His6-βwt)2 and His6-βwt/βwt species ionize with 
similar efficiencies, almost complete exchange is observed in 1 M NaCl and very little in low salt 
buffers. (B) Schematic representation of various homo- and hetero-dimeric sliding clamp 
species. The non-functional protein binding sites on the βC mutant subunits are denoted with . 
(C) (His6-βC)2 is a stable dimer. Positive ion nanoESI mass spectrum of (His6-βC)2 in 200 mM 
ammonium acetate, pH 7.2. (D) NanoESI-MS of purified β heterodimers produced by subunit 
exchange. His6- βwt/βwt (left panel) and His6-βC/βwt (right panel) were dialysed into 200 mM 
ammonium acetate, pH 7.2 before analysis. The His6-βC/βwt that has one binding site in the 
dimer occluded is contaminated by a some (His6-βC)2. However, this construct that has both 




Figure S3  Physical evidence for interaction of β2 with the CBM in ε. (A) SPR sensorgrams 
showing binding of β2 to immobilized εL, εwt and εQ peptides, as indicated. Binding studies were 
carried out by monitoring responses during 60 s of injection of β2 samples in concentration 
series made by twofold serial dilution (the highest and the lowest concentration in each series 
are indicated) followed by 300 s dissociation. For all immobilized peptides, binding of β2 has fast 
on/fast off kinetics. Responses measured at equilibrium were fit to equation 1 (Supplementary 
methods) to generate binding isotherms (Figure 3A) for β2–εLpep (KD = 0.38 ± 0.04 µM; Rmax = 
184 ± 6 RU) and β2–εWTpep (KD = 210 ± 50 µM; Rmax = 327 ± 56 RU) interactions. Due to the 
extremely weak response, we were unable to fit a binding isotherm for the β2–εQpep interaction 
but instead calculated an approximate value of KD. Based on fit Rmax values for β2–εLpep and β2–
εWTpep interactions and measured responses upon immobilization of εLpep, εWTpep and εQpep of 50, 
70 and 60 RUs respectively, the Rmax value for β2–εQpep interaction was ~260 RU. Using the 
measured ~5 RU response resulting from injection of 50 µM β2 and this estimated Rmax, equation 
1 was used to calculate KD (β2–εQpep) ~2.5 mM. (B) Although only few residues away from the 
structured exonuclease domain (Figure 1A), the CBM in εL is accessible to the β2 dimer. Protein 
mixtures (300 µL) of β2 (17 µM) and εQ, εwt or εL (57 µM each), and εL or β2 alone, as indicated, 
were gel filtered through a Sephacryl S-200 HR column (1 x 40 cm). Samples from peak 
fractions were analysed on a 4–12% SDS-PAGE gel, stained with Coomassie blue. The bottom 
panel shows clear evidence of interaction of εL with β2. 
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Figure S4  Simultaneous interaction of the CBM in ε and the internal CBM in α with β2 stabilizes 
the αεθ–β2 Complex. Strengthening of the CBMs in either of the core subunits α or ε results in a 
more stable complex with β2 while αΔ7 and αwt cores show similar binding to β2. Positive ion 
nanoESI mass spectra were acquired as described in the legend to Figure 4, with mixtures of 2 
µM β2 and various αεθ cores. (A) Cores assembled in situ from 0.9 µM αΔ7, αwt, or αL (as 
indicated), 2 µM εQ and 5 mM θ. The assembled cores contain the weakened εQ CBM in ε. (B) 
Cores assembled in situ from 0.9 µM αΔ7, αwt, or αL (as indicated), 2 µM εL and 5 mM θ. The 
assembled cores contain the strengthened εL CBM in ε. 
 
 
Figure S5  Primer extension under “difficult conditions” strongly depends on both β2 and ε, 
which does not have to be active as a proofreader. Primer extension assays (20 min) with 40 nM 
γ3δδ’ and (A) 150 nM α or isolated αεθ complexes in the absence and presence of 200 nM β2, or 
(B) 150 nM α or αε complexes assembled in situ with 150 nM α and 350 nM εwt, εD12A, εD12A,E14A 






Figure S6 Single-molecule (SM) leading strand replication assays. Representative SM 
replication trajectories. Examples of shortening traces including pauses (identified by dashed 
lines) during leading strand synthesis by wild-type Pol III HE assembled in situ as described in 
Supplementary methods. Note that all proteins are present continuously, and replication events 
on any single template DNA commence at random times during these experiments. This reflects 
the low efficiency of DnaC-dependent loading of DnaB in this situation where the template has 
no free 5’ end and no replication origin. Thus DnaB must remain bound at the fork while another 




Figure S7 Single-molecule (SM) leading 
strand replication assays. Available (free) 
DnaC destabilizes DNA synthesis, reflected 
mostly in rate, but also processivity. 
Distribution of DNA synthesis rates (fit with a 
Gaussian distribution) and processivities (fit 
with a single exponential decay) for the 
overall number of events N during leading 
strand synthesis by Pol III HE in cases (A) of 
DnaB6(DnaC)6 assembled in situ from 
approximately stoichiometric DnaB6 (30 nM) 
and DnaC (180 nM) or (B) pre-isolated 
DnaB6(DnaC)6 (standard conditions, 30 nM) 





Figure S8 Single-molecule (SM) leading strand replication assays. The ε–β interaction affects 
both DNA polymerization processivity (left panels) and rate (center) but not duration of 
replication events (right), consistent with its role in stabilizing the replicase in the polymerization 
mode of processive DNA synthesis. Distribution of DNA synthesis rates (fit with a Gaussian 
distribution), processivities and event durations (fit with a single exponential decay) for the 
overall number of events N during leading strand synthesis by Pol III HE assembled in situ with 
α alone, or isolated αεQθ or αεLθ cores (60 nM, standard condition). 
 
 
